Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh DeClercq

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Ustekinumab infusion to subcutaneous transition: Coordinating care and identifying potential gapsChelsea P Renfro, Jessica Fann, Josh DeClercq, et al.
Research in Social & Administrative Pharmacy : RSAP|April 30, 2021
Primary medication nonadherence calculation method specifications impact resulting ratesAutumn D Zuckerman, Josh DeClercq, Nisha B Shah, et al.
Epilepsy Research|January 19, 2024
Adherence and discontinuation of prescription cannabidiol for the management of seizure disorders at an integrated care centerJ Paige Barnes, Holly Dial, Wendi Owens, et al.
American Journal of Surgery|September 22, 2021
Access to hepatitis C direct-acting antiviral therapy in hepatitis C-positive donor to hepatitis C-negative recipient solid-organ transplantation in a real-world settingCori Edmonds, Alicia Carver, Josh DeClercq, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacyMegan E Peter, Autumn D Zuckerman, Josh DeClercq, et al.
Bone|October 5, 2023
Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical settingKatie R Cruchelow, Megan E Peter, Anwesa Chakrabarti, et al.
Multiple Sclerosis and Related Disorders|May 14, 2023
Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysisAutumn D Zuckerman, Josh DeClercq, Dana Simonson, et al.
Digestive Diseases and Sciences|September 19, 2023
Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel DiseaseNisha B Shah, Autumn D Zuckerman, Katie R Hosteng, et al.
Journal of Managed Care & Specialty Pharmacy|September 27, 2019
Navigating the Wild West of Medication Adherence Reporting in Specialty PharmacyScott L Canfield, Autumn Zuckerman, Rebekah H Anguiano, et al.
Journal of the American Pharmacists Association : Japha|January 23, 2022
Primary medication nonadherence to oral oncology specialty medicationsAutumn D Zuckerman, Nisha B Shah, Kristin Perciavalle, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Ustekinumab infusion to subcutaneous transition: Coordinating care and identifying potential gapsChelsea P Renfro, Jessica Fann, Josh DeClercq, et al.
Research in Social & Administrative Pharmacy : RSAP|April 30, 2021
Primary medication nonadherence calculation method specifications impact resulting ratesAutumn D Zuckerman, Josh DeClercq, Nisha B Shah, et al.
Epilepsy Research|January 19, 2024
Adherence and discontinuation of prescription cannabidiol for the management of seizure disorders at an integrated care centerJ Paige Barnes, Holly Dial, Wendi Owens, et al.
American Journal of Surgery|September 22, 2021
Access to hepatitis C direct-acting antiviral therapy in hepatitis C-positive donor to hepatitis C-negative recipient solid-organ transplantation in a real-world settingCori Edmonds, Alicia Carver, Josh DeClercq, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacyMegan E Peter, Autumn D Zuckerman, Josh DeClercq, et al.
Bone|October 5, 2023
Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical settingKatie R Cruchelow, Megan E Peter, Anwesa Chakrabarti, et al.
Multiple Sclerosis and Related Disorders|May 14, 2023
Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysisAutumn D Zuckerman, Josh DeClercq, Dana Simonson, et al.
Digestive Diseases and Sciences|September 19, 2023
Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel DiseaseNisha B Shah, Autumn D Zuckerman, Katie R Hosteng, et al.
Journal of Managed Care & Specialty Pharmacy|September 27, 2019
Navigating the Wild West of Medication Adherence Reporting in Specialty PharmacyScott L Canfield, Autumn Zuckerman, Rebekah H Anguiano, et al.
Journal of the American Pharmacists Association : Japha|January 23, 2022
Primary medication nonadherence to oral oncology specialty medicationsAutumn D Zuckerman, Nisha B Shah, Kristin Perciavalle, et al.
Pageof 6